---
pmid: '24027061'
title: SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease.
authors:
- Echaniz-Laguna A
- Ghezzi D
- Chassagne M
- Mayençon M
- Padet S
- Melchionda L
- Rouvet I
- Lannes B
- Bozon D
- Latour P
- Zeviani M
- Mousson de Camaret B
journal: Neurology
year: '2013'
full_text_available: false
pmcid: PMC3888171
doi: 10.1212/WNL.0b013e3182a4a518
---

# SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease.
**Authors:** Echaniz-Laguna A, Ghezzi D, Chassagne M, Mayençon M, Padet S, Melchionda L, Rouvet I, Lannes B, Bozon D, Latour P, Zeviani M, Mousson de Camaret B
**Journal:** Neurology (2013)
**DOI:** [10.1212/WNL.0b013e3182a4a518](https://doi.org/10.1212/WNL.0b013e3182a4a518)
**PMC:** [PMC3888171](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888171/)

## Abstract

1. Neurology. 2013 Oct 22;81(17):1523-30. doi: 10.1212/WNL.0b013e3182a4a518. Epub
 2013 Sep 11.

SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease.

Echaniz-Laguna A(1), Ghezzi D, Chassagne M, Mayençon M, Padet S, Melchionda L, 
Rouvet I, Lannes B, Bozon D, Latour P, Zeviani M, Mousson de Camaret B.

Author information:
(1)From the Département de Neurologie (A.E.-L.), Hôpitaux Universitaires, 
Strasbourg; INSERM U692 (A.E.-L.), Université de Strasbourg, France; Unit of 
Molecular Neurogenetics (D.G., L.M., M.Z.), Fondazione Istituto Neurologico 
Carlo Besta, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy; 
Service des Maladies Héréditaires du Métabolisme (M.C., M.M., S.P., B.M.deC.), 
Centre de Biotechnologie Cellulaire (I.R.), Unité de Cardiogénétique Moléculaire 
(D.B.), and Service de Neurobiologie (P.L.), Centre de Biologie et de Pathologie 
Est, CHU Lyon, Bron, France; and Département d'Anatomopathologie (B.L.), 
Hôpitaux Universitaires, Strasbourg, France.

OBJECTIVE: To investigate whether mutations in the SURF1 gene are a cause of 
Charcot-Marie-Tooth (CMT) disease.
METHODS: We describe 2 patients from a consanguineous family with demyelinating 
autosomal recessive CMT disease (CMT4) associated with the homozygous splice 
site mutation c.107-2A>G in the SURF1 gene, encoding an assembly factor of the 
mitochondrial respiratory chain complex IV. This observation led us to 
hypothesize that mutations in SURF1 might be an unrecognized cause of CMT4, and 
we investigated SURF1 in a total of 40 unrelated patients with CMT4 after 
exclusion of mutations in known CMT4 genes. The functional impact of c.107-2A>G 
on splicing, amount of SURF1 protein, and on complex IV activity and assembly 
was analyzed.
RESULTS: Another patient with CMT4 was found to harbor 2 additional SURF1 
mutations. All 3 patients with SURF1-associated CMT4 presented with severe 
childhood-onset neuropathy, motor nerve conduction velocities <25 m/s, and 
lactic acidosis. Two patients had brain MRI abnormalities, including putaminal 
and periaqueductal lesions, and developed cerebellar ataxia years after 
polyneuropathy. The c.107-2A>G mutation produced no normally spliced transcript, 
leading to SURF1 absence. However, complex IV remained partially functional in 
muscle and fibroblasts.
CONCLUSIONS: We found SURF1 mutations in 5% of families (2/41) presenting with 
CMT4. SURF1 should be systematically screened in patients with childhood-onset 
severe demyelinating neuropathy and additional features such as lactic acidosis, 
brain MRI abnormalities, and cerebellar ataxia developing years after 
polyneuropathy.

DOI: 10.1212/WNL.0b013e3182a4a518
PMCID: PMC3888171
PMID: 24027061 [Indexed for MEDLINE]
